论文部分内容阅读
目的观察低分子肝素联合波立维治疗急性脑梗死近期疗效及安全性。方法将131例急性脑梗死患者随机分为治疗组和对照组,其中治疗组66例,对照组65例;治疗组给予低分子肝素联合波利维治疗,对照组给予常规治疗。结果低分子肝素联合波利维治疗急性脑梗死神经缺损程度及临床疗效显著提高。结论低分子肝素联合氯吡格雷(波立维)治疗急性进展性脑梗死是安全有效的方法。
Objective To observe the short-term curative effect and safety of low molecular weight heparin combined with polio in the treatment of acute cerebral infarction. Methods 131 cases of acute cerebral infarction were randomly divided into treatment group and control group, including 66 cases in the treatment group and 65 cases in the control group. The treatment group was given low molecular weight heparin combined with Pollyvist and the control group was given routine treatment. Results Low molecular weight heparin combined with polivaril treatment of acute cerebral infarction, the degree of neurological deficit and clinical efficacy significantly increased. Conclusions Low molecular weight heparin combined with clopidogrel is a safe and effective method for the treatment of acute progressive cerebral infarction.